Menu
GeneBe

POMT2

protein O-mannosyltransferase 2, the group of Dolichyl D-mannosyl phosphate dependent mannosyltransferases

Basic information

Region (hg38): 14:77274955-77320883

Links

ENSG00000009830NCBI:29954OMIM:607439HGNC:19743Uniprot:Q9UKY4AlphaFoldGenCCjaxSfariGnomADPubmedClinVar

Phenotypes

GenCC

Source: genCC

  • muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A2 (Definitive), mode of inheritance: AR
  • muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A2 (Strong), mode of inheritance: AR
  • muscular dystrophy-dystroglycanopathy (congenital with intellectual disability), type B2 (Moderate), mode of inheritance: AR
  • muscular dystrophy-dystroglycanopathy, type A (Supportive), mode of inheritance: AR
  • muscle-eye-brain disease (Supportive), mode of inheritance: AR
  • autosomal recessive limb-girdle muscular dystrophy type 2N (Supportive), mode of inheritance: AR
  • congenital muscular dystrophy with cerebellar involvement (Supportive), mode of inheritance: AR
  • congenital muscular dystrophy with intellectual disability (Supportive), mode of inheritance: AR
  • muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A2 (Strong), mode of inheritance: AR
  • myopathy caused by variation in POMT2 (Definitive), mode of inheritance: AR

Clinical Genomic Database

Source: CGD

ConditionInheritanceIntervention CategoriesIntervention/Rationale Manifestation CategoriesReferences
Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A, 2 ; Muscular dystrophy-dystroglycanopathy (congenital with mental retardation), type B, 2; Muscular dystrophy-dystroglycanopathy (limb-girdle), type C 2ARCardiovascularConditions may involve cardiovascular manifestations (including dilated cardiomyopathy) and surveillance (eg, with echocardiography) may allow early medical managementCardiovascular; Musculoskeletal; Neurologic; Ophthalmologic15894594; 16701995; 17923109; 17878207; 19067344; 19299310; 19138766; 20301468; 20816175; 22727687

ClinVar

This is a list of variants' phenotypes submitted to ClinVar and linked to the POMT2 gene.

  • Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A2;Muscular dystrophy-dystroglycanopathy (congenital with intellectual disability), type B2;Autosomal recessive limb-girdle muscular dystrophy type 2N (447 variants)
  • not provided (334 variants)
  • Autosomal recessive limb-girdle muscular dystrophy type 2N (132 variants)
  • not specified (86 variants)
  • Muscular dystrophy-dystroglycanopathy (congenital with intellectual disability), type B2;Autosomal recessive limb-girdle muscular dystrophy type 2N;Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A2 (62 variants)
  • Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A2 (56 variants)
  • Autosomal recessive limb-girdle muscular dystrophy type 2N;Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A2;Muscular dystrophy-dystroglycanopathy (congenital with intellectual disability), type B2 (50 variants)
  • Inborn genetic diseases (26 variants)
  • Autosomal recessive limb-girdle muscular dystrophy type 2N;Muscular dystrophy-dystroglycanopathy (congenital with intellectual disability), type B2;Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A2 (25 variants)
  • Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A1;Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A2;Muscular dystrophy-dystroglycanopathy (congenital with intellectual disability), type B2;Autosomal recessive limb-girdle muscular dystrophy type 2N (12 variants)
  • Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A2;Autosomal recessive limb-girdle muscular dystrophy type 2N;Muscular dystrophy-dystroglycanopathy (congenital with intellectual disability), type B2 (10 variants)
  • Muscular dystrophy-dystroglycanopathy (congenital with intellectual disability), type B2 (10 variants)
  • Muscular dystrophy-dystroglycanopathy (congenital with intellectual disability), type B2;Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A2;Autosomal recessive limb-girdle muscular dystrophy type 2N (7 variants)
  • Limb-Girdle Muscular Dystrophy, Recessive (6 variants)
  • Autosomal recessive limb-girdle muscular dystrophy (5 variants)
  • Muscular dystrophy (3 variants)
  • POMT2-related condition (3 variants)
  • Intellectual disability (2 variants)
  • Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A2;Muscular dystrophy-dystroglycanopathy (congenital with intellectual disability), type B2;Autosomal recessive limb-girdle muscular dystrophy type 2N;Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A1 (2 variants)
  • Abnormal brain morphology (1 variants)
  • Autosomal recessive limb-girdle muscular dystrophy type 2N;Muscular dystrophy-dystroglycanopathy (congenital with intellectual disability), type B2;Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A1;Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A2 (1 variants)
  • POMGNT1-Related Disorders (1 variants)
  • See cases (1 variants)
  • Congenital muscular alpha-dystroglycanopathy with brain and eye anomalies (1 variants)
  • Muscular dystrophy-dystroglycanopathy (congenital with intellectual disability), type B2;Autosomal recessive limb-girdle muscular dystrophy type 2N;Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A1;Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A2 (1 variants)
  • - (1 variants)
  • Congenital muscular dystrophy (1 variants)

Variants pathogenicity by type

Statistics on ClinVar variants can assist in determining whether a specific variant type in the POMT2 gene is commonly pathogenic or not.

In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.

Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.

Variant type Pathogenic Likely pathogenic VUS Likely benign Benign Sum
synonymous
15
clinvar
104
clinvar
5
clinvar
124
missense
1
clinvar
7
clinvar
326
clinvar
3
clinvar
2
clinvar
339
nonsense
14
clinvar
6
clinvar
1
clinvar
21
start loss
0
frameshift
12
clinvar
18
clinvar
2
clinvar
32
inframe indel
5
clinvar
5
splice donor/acceptor (+/-2bp)
7
clinvar
21
clinvar
1
clinvar
29
splice region
26
29
2
57
non coding
1
clinvar
74
clinvar
110
clinvar
60
clinvar
245
Total 34 53 424 217 67

Highest pathogenic variant AF is 0.0000328

Variants in POMT2

This is a list of pathogenic ClinVar variants found in the POMT2 region.

You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.

Position Type Phenotype Significance ClinVar
14-77274995-T-C Autosomal recessive limb-girdle muscular dystrophy type 2N Uncertain significance (Jan 12, 2018)884604
14-77275006-C-CT Limb-Girdle Muscular Dystrophy, Recessive Uncertain significance (Jun 14, 2016)314506
14-77275017-T-A Autosomal recessive limb-girdle muscular dystrophy type 2N Uncertain significance (Jan 12, 2018)884605
14-77275051-T-C Autosomal recessive limb-girdle muscular dystrophy type 2N Benign (Jan 13, 2018)314507
14-77275176-C-T Autosomal recessive limb-girdle muscular dystrophy type 2N Uncertain significance (Jan 12, 2018)884606
14-77275211-A-G Autosomal recessive limb-girdle muscular dystrophy type 2N Uncertain significance (Jan 12, 2018)314508
14-77275216-A-G Limb-Girdle Muscular Dystrophy, Recessive Uncertain significance (Jun 14, 2016)314509
14-77275225-T-C Autosomal recessive limb-girdle muscular dystrophy type 2N Conflicting classifications of pathogenicity (Jun 01, 2023)314510
14-77275283-T-C Autosomal recessive limb-girdle muscular dystrophy type 2N Uncertain significance (Jan 13, 2018)314511
14-77275285-C-A Autosomal recessive limb-girdle muscular dystrophy type 2N Likely benign (Jan 12, 2018)314512
14-77275296-C-T Autosomal recessive limb-girdle muscular dystrophy type 2N Uncertain significance (Jan 13, 2018)885541
14-77275299-A-G Autosomal recessive limb-girdle muscular dystrophy type 2N Uncertain significance (Jan 13, 2018)885542
14-77275304-G-A Autosomal recessive limb-girdle muscular dystrophy type 2N Uncertain significance (Jan 12, 2018)314513
14-77275323-G-T Autosomal recessive limb-girdle muscular dystrophy type 2N Uncertain significance (Jan 13, 2018)885543
14-77275402-C-T Autosomal recessive limb-girdle muscular dystrophy type 2N Benign (Jan 13, 2018)314514
14-77275409-G-A Autosomal recessive limb-girdle muscular dystrophy type 2N Benign (Jan 13, 2018)314515
14-77275470-C-T Autosomal recessive limb-girdle muscular dystrophy type 2N Uncertain significance (Jan 12, 2018)885544
14-77275483-C-T Autosomal recessive limb-girdle muscular dystrophy type 2N Likely benign (Jan 12, 2018)886564
14-77275558-A-G Autosomal recessive limb-girdle muscular dystrophy type 2N Uncertain significance (Jan 13, 2018)886565
14-77275571-C-T Autosomal recessive limb-girdle muscular dystrophy type 2N Uncertain significance (Jan 12, 2018)314516
14-77275602-G-A Autosomal recessive limb-girdle muscular dystrophy type 2N Uncertain significance (Jan 12, 2018)886566
14-77275620-G-A Autosomal recessive limb-girdle muscular dystrophy type 2N Likely benign (Jan 12, 2018)314517
14-77275627-G-T Autosomal recessive limb-girdle muscular dystrophy type 2N Uncertain significance (Jan 12, 2018)314518
14-77275628-G-T Autosomal recessive limb-girdle muscular dystrophy type 2N Benign (Jan 12, 2018)314519
14-77275634-C-T Autosomal recessive limb-girdle muscular dystrophy type 2N Benign (Jan 13, 2018)314520

GnomAD

Source: gnomAD

GeneTypeBio TypeTranscript Coding Exons Length
POMT2protein_codingprotein_codingENST00000261534 2145929
pLI Probability
LOF Intolerant
pRec Probability
LOF Recessive
Individuals with
no LOFs
Individuals with
Homozygous LOFs
Individuals with
Heterozygous LOFs
Defined p
9.43e-120.9941256800681257480.000270
Z-Score Observed Expected Observed/Expected Mutation Rate Total Possible in Transcript
Missense0.07634124160.9890.00002364818
Missense in Polyphen121154.130.785041830
Synonymous0.2891621670.9720.000009201523
Loss of Function2.652543.90.5690.00000232473

LoF frequencies by population

EthnicitySum of pLOFs p
African & African-American0.0004460.000445
Ashkenazi Jewish0.000.00
East Asian0.0004360.000435
Finnish0.0001390.000139
European (Non-Finnish)0.0002760.000273
Middle Eastern0.0004360.000435
South Asian0.0003940.000392
Other0.0003260.000326

dbNSFP

Source: dbNSFP

Function
FUNCTION: Transfers mannosyl residues to the hydroxyl group of serine or threonine residues. Coexpression of both POMT1 and POMT2 is necessary for enzyme activity, expression of either POMT1 or POMT2 alone is insufficient. {ECO:0000269|PubMed:14699049}.;
Disease
DISEASE: Muscular dystrophy-dystroglycanopathy congenital with brain and eye anomalies A2 (MDDGA2) [MIM:613150]: An autosomal recessive disorder characterized by congenital muscular dystrophy associated with cobblestone lissencephaly and other brain anomalies, eye malformations, profound mental retardation, and death usually in the first years of life. Included diseases are the more severe Walker-Warburg syndrome and the slightly less severe muscle-eye-brain disease. {ECO:0000269|PubMed:15894594, ECO:0000269|PubMed:16701995, ECO:0000269|PubMed:17878207, ECO:0000269|PubMed:19138766, ECO:0000269|PubMed:22958903}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Muscular dystrophy-dystroglycanopathy congenital with mental retardation B2 (MDDGB2) [MIM:613156]: An autosomal recessive disorder characterized by congenital muscular dystrophy associated with mental retardation and mild structural brain abnormalities. {ECO:0000269|PubMed:17634419, ECO:0000269|PubMed:19299310}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Muscular dystrophy-dystroglycanopathy limb-girdle C2 (MDDGC2) [MIM:613158]: An autosomal recessive muscular dystrophy with onset after ambulation is achieved. MDDGC2 is characterized by increased serum creatine kinase and mild muscle weakness. Muscle biopsy shows dystrophic changes, inflammatory changes, and severely decreased alpha-dystroglycan. Cognition is normal. {ECO:0000269|PubMed:17878207, ECO:0000269|PubMed:17923109}. Note=The disease is caused by mutations affecting the gene represented in this entry.;
Pathway
Other types of O-glycan biosynthesis - Homo sapiens (human);Mannose type O-glycan biosynthesis - Homo sapiens (human);Post-translational protein modification;Metabolism of proteins;O-linked glycosylation (Consensus)

Recessive Scores

pRec
0.190

Intolerance Scores

loftool
0.152
rvis_EVS
-0.93
rvis_percentile_EVS
9.68

Haploinsufficiency Scores

pHI
0.341
hipred
N
hipred_score
0.414
ghis
0.587

Essentials

essential_gene_CRISPR
N
essential_gene_CRISPR2
N
essential_gene_gene_trap
N
gene_indispensability_pred
N
gene_indispensability_score
0.459

Gene Damage Prediction

AllRecessiveDominant
MendelianMediumMediumMedium
Primary ImmunodeficiencyMediumMediumMedium
CancerMediumMediumMedium

Mouse Genome Informatics

Gene name
Pomt2
Phenotype
cellular phenotype; growth/size/body region phenotype; nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); embryo phenotype;

Zebrafish Information Network

Gene name
pomt2
Affected structure
post-vent region
Phenotype tag
abnormal
Phenotype quality
kinked

Gene ontology

Biological process
protein O-linked mannosylation;ER-associated misfolded protein catabolic process;positive regulation of protein O-linked glycosylation
Cellular component
endoplasmic reticulum membrane;integral component of membrane
Molecular function
dolichyl-phosphate-mannose-protein mannosyltransferase activity;metal ion binding